19-42868762-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001184825.2(PSG1):c.982G>A(p.Val328Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000565 in 1,611,976 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001184825.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000145 AC: 22AN: 151478Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.0000399 AC: 9AN: 225780Hom.: 0 AF XY: 0.00000831 AC XY: 1AN XY: 120390
GnomAD4 exome AF: 0.0000404 AC: 59AN: 1460380Hom.: 2 Cov.: 42 AF XY: 0.0000427 AC XY: 31AN XY: 726468
GnomAD4 genome AF: 0.000211 AC: 32AN: 151596Hom.: 2 Cov.: 32 AF XY: 0.0000675 AC XY: 5AN XY: 74056
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 26, 2024 | The c.982G>A (p.V328I) alteration is located in exon 4 (coding exon 4) of the PSG1 gene. This alteration results from a G to A substitution at nucleotide position 982, causing the valine (V) at amino acid position 328 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at